Chongqing, China

Liyun Zou

This inventor holds 1 USPTO granted patent. Top assignees: Chongqing Jiachen Bioengineering Co., Ltd., Institute of Immunology, Pla. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liyun Zou. Retrieved from https://idiyas.com/inventor/liyun-zou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liyun Zou: Innovator in Hepatitis B Treatment

Introduction

Liyun Zou is a notable inventor based in Chongqing, China. He has made significant contributions to the field of immunology, particularly in the development of therapeutic vaccines for hepatitis B. His innovative work has the potential to impact the treatment landscape for this viral infection.

Latest Patents

Liyun Zou holds a patent for an immunogen designed for the preparation of therapeutic vaccines or drugs aimed at treating hepatitis B. The patent details the immunogens' preparation and use, as well as the vaccines or medicaments that incorporate these immunogens. This invention represents a crucial advancement in the fight against hepatitis B.

Career Highlights

Throughout his career, Liyun Zou has worked with esteemed organizations such as the Institute of Immunology and Chongqing Jiachen Bioengineering Co., Ltd. His experience in these institutions has allowed him to refine his expertise in immunology and vaccine development.

Collaborations

Liyun Zou has collaborated with notable colleagues, including Tongdong Shi and Yuzhang Wu. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of hepatitis B treatment.

Conclusion

Liyun Zou's contributions to immunology and his innovative patent for hepatitis B treatment highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in therapeutic solutions for viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…